On the other hand, decreased expression of ACP6 was found to contribute to increased cell mortality and disease progression in high-grade serous ovarian cancer and esophageal squamous cell carcinoma (78, 79). This evidence concerns the gene ACP6 and ovarian serous adenocarcinoma.